Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Other Non-Current Liabilities (2018 - 2024)

Historic Other Non-Current Liabilities for Pharma-Bio Serv (PBSV) over the last 8 years, with Q4 2024 value amounting to $660903.0.

  • Pharma-Bio Serv's Other Non-Current Liabilities changed N/A to $660903.0 in Q4 2024 from the same period last year, while for Oct 2024 it was $660903.0, marking a year-over-year change of. This contributed to the annual value of $660903.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, Pharma-Bio Serv's Other Non-Current Liabilities is $660903.0.
  • Over the past 5 years, Pharma-Bio Serv's Other Non-Current Liabilities peaked at $1.6 million during Q4 2022, and registered a low of $17950.0 during Q1 2020.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $17950.0 (2020), whereas its average is $385000.7.
  • In the last 5 years, Pharma-Bio Serv's Other Non-Current Liabilities crashed by 9676.7% in 2020 and then soared by 903118.66% in 2022.
  • Pharma-Bio Serv's Other Non-Current Liabilities (Quarter) stood at $73389.0 in 2020, then tumbled by 75.54% to $17950.0 in 2021, then skyrocketed by 9031.19% to $1.6 million in 2022, then dropped by 12.9% to $1.4 million in 2023, then plummeted by 53.7% to $660903.0 in 2024.
  • Its Other Non-Current Liabilities stands at $660903.0 for Q4 2024, versus $1.4 million for Q3 2023 and $1.4 million for Q2 2023.